News

Emcure launches generic metastatic breast cancer drug in India

The company will manufacture the product at its plant at Hinjewadi in Pune and market it at a cost which will be approximately 40 per cent less than the innovator brand.

Apr 04, 2019

By : Team ABLE

DBT has announced application call for 2019 B4 Young Scientist Workshop

This year the workshop will focus on exciting new technologies and analytical solutions in light microscopy.

Apr 04, 2019

By : Team ABLE

FDA Commissioner Scott Gottlieb releases statement on Advancing Beneficial Animal Biotechnology Product Development

This week, the Commissioner, has highlighted the department’s ongoing implementation of its risk-based regulation of the safety and effectiveness of heritable intentional genomic alterations in animals.

Apr 04, 2019

By : Team ABLE

CDC modifies advisory against travelling to India based on Zika Virus status; ICMR furthers Zika virus study

The Indian Government had urged the US to withdraw or modify its advisory in January by providing evidence of the contained Zika Virus outbreak in the country.

Apr 02, 2019

By : Team ABLE

AstraZeneca, Daiichi Sankyo enter collaboration for novel HER2-targeting antibody-drug conjugate

Trastuzumab deruxtecan is currently in development for the treatment of multipleHER2-expressing cancers, including breast and gastric cancer, and in patients withHER2-low expression.

Apr 02, 2019

By : Team ABLE